This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Sugiyama Shimpei: Innovator in Thromboxane A2 Receptor Antagonists
Introduction
Sugiyama Shimpei is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of thromboxane A2 (TP) receptor antagonists. His work focuses on innovative compounds that have the potential to cross the blood-brain barrier, offering new avenues for treatment.
Latest Patents
Sugiyama holds 1 patent related to his research on TP receptor antagonists. The patent details novel compounds that can be utilized in methods for treating disorders associated with the activation of the TP receptor. This advancement could lead to improved therapeutic strategies for various medical conditions.
Career Highlights
Sugiyama is affiliated with the University of Pennsylvania, where he continues to engage in groundbreaking research. His academic background and ongoing projects contribute to the advancement of medical science, particularly in understanding and manipulating receptor activity for therapeutic benefits.
Collaborations
Throughout his career, Sugiyama has collaborated with esteemed colleagues, including John Q Trojanowski and Virginia Man-Yee Lee. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.
Conclusion
Sugiyama Shimpei's work in developing thromboxane A2 receptor antagonists represents a significant step forward in pharmacological research. His contributions are poised to influence future treatments and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile